Medpace Holdings, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for MEDP, updated each market day.
MEDP AI Sentiment
AI predicts Medpace Holdings, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Medpace Holdings, Inc. Common Stock
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Sector
Exchange
Market Cap
$14,321,856,558
Cap Tier
Employees
6,200
Headquarters
CINCINNATI, OH
Listed Since
Aug. 11, 2016
Website
MEDP Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
MEDP Volatility
Medpace Holdings, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
